GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » 3-Year EBITDA Growth Rate

AroCell AB (OSTO:AROC) 3-Year EBITDA Growth Rate : 38.30% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB 3-Year EBITDA Growth Rate?

AroCell AB's EBITDA per Share for the three months ended in Dec. 2023 was kr-0.07.

During the past 3 years, the average EBITDA Per Share Growth Rate was 38.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 39.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of AroCell AB was 54.00% per year. The lowest was -31.40% per year. And the median was 14.70% per year.


Competitive Comparison of AroCell AB's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, AroCell AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AroCell AB's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, AroCell AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where AroCell AB's 3-Year EBITDA Growth Rate falls into.



AroCell AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


AroCell AB  (OSTO:AROC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


AroCell AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of AroCell AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB (OSTO:AROC) Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings allé 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

AroCell AB (OSTO:AROC) Headlines

From GuruFocus

Archrock to Partner with ECOTEC on Methane Emissions Management

By GuruFocusNews GuruFocusNews 04-25-2022

Archrock Announces Timing for Second Quarter 2022 Results

By PurpleRose PurpleRose 07-18-2022

Archrock Announces Quarterly Cash Dividend

By GlobeNewswire 10-26-2023

Archrock Increases Quarterly Cash Dividend

By GlobeNewswire GlobeNewswire 01-26-2023

Archrock Announces Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 04-28-2022

Archrock Publishes its 2021 Annual Sustainability Report

By PurpleRose PurpleRose 08-11-2022

Archrock Announces Timing for First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 05-02-2022